-transparent.png){kind=logo}
The new, long acting converting enzyme inhibitor enalapril was given to 26 patients with moderate to severe heart failure. In 23 cases the mean systolic blood pressure fell from 120 (SD 22) to 108 (25) mm Hg without adverse effects. Profound hypotension with severe bradycardia and sweating, however, occurred in three patients, most pronounced two to four hours after the first dose. The haemodynamic and biochemical changes in these patients were similar to those seen in patients with severe symptomatic hypotension after the first dose of the converting enzyme inhibitor captopril, except that with enalapril the changes occurred later and were longer lasting. Evidence of myocardial damage and reversible renal failure was seen in one patient, and acute reversible deterioration in renal function occurred in one other. In patients with heart failure converting enzyme inhibitors should be administered initially under strict medical supervision with appropriate facilities available for dealing with occasional profound hypotension.
J G Cleland, and
H J Dargie, and
H McAlpine, and
S G Ball, and
J J Morton, and
J I Robertson, and
I Ford
June 1991,
International journal of cardiology,
J G Cleland, and
H J Dargie, and
H McAlpine, and
S G Ball, and
J J Morton, and
J I Robertson, and
I Ford
April 1989,
Cardiovascular drugs and therapy,
J G Cleland, and
H J Dargie, and
H McAlpine, and
S G Ball, and
J J Morton, and
J I Robertson, and
I Ford
January 1991,
Zeitschrift fur Kardiologie,
J G Cleland, and
H J Dargie, and
H McAlpine, and
S G Ball, and
J J Morton, and
J I Robertson, and
I Ford
October 1991,
Ugeskrift for laeger,
J G Cleland, and
H J Dargie, and
H McAlpine, and
S G Ball, and
J J Morton, and
J I Robertson, and
I Ford
December 2004,
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia,
J G Cleland, and
H J Dargie, and
H McAlpine, and
S G Ball, and
J J Morton, and
J I Robertson, and
I Ford
September 2000,
European journal of heart failure,
J G Cleland, and
H J Dargie, and
H McAlpine, and
S G Ball, and
J J Morton, and
J I Robertson, and
I Ford
February 1990,
Deutsche medizinische Wochenschrift (1946),
J G Cleland, and
H J Dargie, and
H McAlpine, and
S G Ball, and
J J Morton, and
J I Robertson, and
I Ford
January 1993,
The Journal of the Association of Physicians of India,
J G Cleland, and
H J Dargie, and
H McAlpine, and
S G Ball, and
J J Morton, and
J I Robertson, and
I Ford
April 1992,
The Journal of the Association of Physicians of India,
J G Cleland, and
H J Dargie, and
H McAlpine, and
S G Ball, and
J J Morton, and
J I Robertson, and
I Ford
November 2001,
Cardiovascular drugs and therapy,
